PAPER Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, Bhaduri A, Goyal N, Rowitch DH, Kriegstein AR
SEARCH RESULTS
4087 RESULTS
Priya Gami-Patel
Verena Zyka
University of CambridgeCambridge, United Kingdom
PAPER Jiang LL, Zhu B, Zhao Y, Li X, Liu T, Pina-Crespo J, Zhou L, Xu W, Rodriguez MJ, Yu H, Cleveland DW, Ravits J, Da Cruz S, Long T, Zhang D, Huang TY, Xu H
Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment.
J Clin Invest. 2019 May 21;129(8):3103-3120. PubMed: 31112137PAPER Verkhratsky A
Astroglial Calcium Signaling in Aging and Alzheimer's Disease.
Cold Spring Harb Perspect Biol. 2019 Jul 1;11(7) PubMed: 31110130PAPER Hartlage-Rübsamen M, Ratz V, Zeitschel U, Finzel L, Machner L, Köppen J, Schulze A, Demuth HU, von Hörsten S, Höfling C, Roßner S
Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer's disease.
Acta Neuropathol Commun. 2019 May 20;7(1):79. PubMed: 31109380PAPER Krejciova Z, Carlson GA, Giles K, Prusiner SB
Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
Acta Neuropathol Commun. 2019 May 20;7(1):81. PubMed: 31109379PAPER Petit D, Hitzenberger M, Lismont S, Zoltowska KM, Ryan NS, Mercken M, Bischoff F, Zacharias M, Chávez-Gutiérrez L
Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators.
EMBO J. 2019 Jun 17;38(12) Epub 2019 May 20 PubMed: 31109937PAPER Kuo YC, Rajesh R
Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.
Expert Rev Neurother. 2019 Jul;19(7):623-652. Epub 2019 May 29 PubMed: 31109210PAPER Ghasemi Tigan M, Ghahghaei A, Lagzian M
In-vitro and in-silico investigation of protective mechanisms of crocin against E46K α-synuclein amyloid formation.
Mol Biol Rep. 2019 Aug;46(4):4279-4292. Epub 2019 May 20 PubMed: 31111370PAPER Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
Sci Rep. 2019 May 21;9(1):7567. PubMed: 31110191PAPER Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER, Roy S
Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11113-11115. Epub 2019 May 20 PubMed: 31110017PAPER Atias M, Tevet Y, Sun J, Stavsky A, Tal S, Kahn J, Roy S, Gitler D
Synapsins regulate α-synuclein functions.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11116-11118. Epub 2019 May 20 PubMed: 31110014PAPER Dhillon JS, Trejo-Lopez JA, Riffe C, Levites Y, Sacino AN, Borchelt DR, Yachnis AY, Giasson BI
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Acta Neuropathol Commun. 2019 May 20;7(1):80. PubMed: 31109378PAPER Freedman DM, Kuncl RW, Cahoon EK, Rivera DR, Pfeiffer RM
Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):538-546. PubMed: 31112080Current Filters
- Date Range : Feb 2019 to May 2019 x